IT IS NOW recognized that smooth muscle cell proliferation plays an important role in the formation of the proliferative lesions of atherosclerosis.' The involvement of platelet-derived growth factor (PDGF) in this process was suggested by an observation made by Russell Ross and his collaborators in the early 1970s that cultured arterial smooth muscle cells grew poorly in plasma-derived serum and that addition of platelet extract greatly increased the growth rate. 6 the platelets -none can be detected in the plasma.8 9 At sites of platelet adhesion and/or activation, platelets release the contents of their alpha granules."1 The PDGF that is released is predicted to bind to, and activate, nearby smooth muscle cells.7 This model provides a mechanism for the topical administration of growth factors to sites at which they are necessary for promoting tissue regeneration. Discoveries in the last few years, however, suggest both narrower and wider views of the role of PDGF in vascular biology: wider in that they suggest PDGF may be provided at sites of vascular trauma by mechanisms in addition to plateletdegranulation, and narrower in that they suggest PDGF is not the only important polypeptide growth factor present in platelets.
It was difficult to study PDGF critically when it could be identified only as a growth-promoting substance from platelets. However, PDGF has now been purified in several laboratories, 1 Monolayer cultures of each cell type were prepared in 24-well culture trays. When the cutlures were confluent, the medium was replaced with culture medium containing 2% plasma-derived serum or 2% calf whole blood serum from which the PDGF had been removed by cation exchange chromatography.56 After 2 days, the cultures were rinsed once with ice-cold saline, then incubated for 4 hr at 40 C with gentle oscillation in I ml of medium containing 0.25% bovine serum albumin and the concentration of 125I-PDGF shown on the abscissa, or with 1251-PDGF plus a 1 00-fold excess of unlabeled PDGF to determine nonspecific binding (always less than 15% of total binding), or with medium alone to determine cell number by electronic particle counting. 38 We have recently reported39 that production of a PDGF-c by adult rat smooth muscle cells might also be activated under conditions associated with wounding. In these studies, the carotid artery was deendothelialized with a balloon catheter. Two The third growth factor is a so-called transforming growth factor. TGFs are operationally defined as substances that promote the growth in suspension of cul tured cells that otherwise require attachment to a substratum.46 Ability to grow in soft agar is one of the characteristics of oncogenically transformed cells that most reliably distinguishes them from their nontransformed counterparts.47 Class alpha TGFs were first found to be secreted by cultured transformed cells. They resemble EGF in that they bind to the EGF receptoit and are related to them in amino acid sequence. 49 Class beta TGFs do not bind to the EGF receptor and depend on the presence of EGF in order to display optimal ability to promote growth in soft agar.1`51 Surprisingly, the normal tissue richest in class beta TGFs seems to be the blood platelets.12-l Assoian et al. 4 have provided evidence that the TGF beta in platelets may be strongly supported in its activity by 738 EGF and PDGF together, so that a platelet contains a complete set of the three growth factors needed to support optimal growth in soft agar: PDGF, EGF, and TGF-beta.
It is intriguing to speculate on why normal platelets contain factors that are associated with the production of the transformed phenotype. One possibility is that the environment of a smooth muscle cell in a damaged artery, and possibly in a normal artery as well, is not identical to that of an attached cell in monolayer culture and that it shares some characteristics with suspension in soft agar. Figure 2 is We would like to thank Mara Berkley for typing the manuscript.
